Physician
Bethany Medical Center
Bethany Medical Center was paid $4.74M by Medicaid between Aug 2018 and Dec 2024, across 73 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoBETHANY MEDICAL CENTER
WINSTON SALEM, NC 27103
WINSTON SALEM, NC 27103
33aNPI1528554631assigned 07/02/2018
33bProvider typePain Medicine Physician
28Total paid$4.74M
24GClaims136,203
24DCodes billed73
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers
Next to other Pain Medicine Physician providers in North Carolina
Rank by total paid#3 of 17
Median peer was paid$197K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PETERS, LENIN controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,488 | $246K | |
| 2019 | 19,896 | $1.01M | |
| 2020 | 21,645 | $1.15M | |
| 2021 | 14,807 | $583K | |
| 2022 | 14,196 | $483K | |
| 2023 | 27,139 | $622K | |
| 2024incomplete | 33,032 | $636K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 30,750 | 24,735 | $1.57M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 24% | 17,304 | 15,091 | $1.16M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 12% | 8,536 | 7,616 | $579K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 12% | 5,414 | 4,927 | $566K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.0% | 9,827 | 7,883 | $283K |
| 99199 | Unlisted special service, procedure or report | 3.4% | 22,534 | 11,822 | $162K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.6% | 1,891 | 1,454 | $124K |
| 83970 | <1% | 731 | 601 | $30K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,019 | 822 | $30K |
| 86769 | <1% | 744 | 724 | $29K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,411 | 1,080 | $22K |
| 80061 | Lipid panel | <1% | 1,362 | 1,146 | $18K |
61 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 365 | $18K |
| 80053 | Comprehensive metabolic panel | <1% | 1,832 | $17K |
| 99406 | <1% | 2,549 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,798 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,276 | $12K |
| 84480 | <1% | 802 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 496 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,806 | $8K |
| 82607 | <1% | 515 | $7K | |
| 84439 | <1% | 805 | $7K | |
| 82746 | <1% | 512 | $7K | |
| 82728 | <1% | 513 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 161 | $6K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 69 | $4K |
| 83550 | <1% | 513 | $4K | |
| 72100 | <1% | 208 | $4K | |
| 83540 | <1% | 332 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 883 | $2K |
| 80050 | General health panel | <1% | 193 | $2K |
| 81025 | <1% | 213 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 22 | $895.72 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,107 | $725.58 |
| 72050 | <1% | 29 | $578.64 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 18 | $543.89 |
| 93000 | <1% | 47 | $495.72 | |
| 94375 | <1% | 27 | $492.49 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 20 | $482.62 |
| 86703 | <1% | 44 | $437.50 | |
| 86431 | <1% | 54 | $310.53 | |
| 84550 | <1% | 71 | $305.57 | |
| 90688 | <1% | 21 | $285.60 | |
| 99442 | <1% | 17 | $274.08 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 118 | $265.64 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 20 | $209.55 |
| 81002 | <1% | 97 | $198.45 | |
| 86803 | <1% | 16 | $176.10 | |
| 87340 | <1% | 16 | $114.80 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 174 | $105.90 |
| 96146 | <1% | 498 | $79.38 | |
| 3044F | <1% | 687 | $60.00 | |
| 82044 | <1% | 18 | $24.71 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 201 | $18.74 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $12.16 |
| 3077F | 0% | 69 | $0.00 | |
| 4004F | 0% | 914 | $0.00 | |
| 3078F | 0% | 1,584 | $0.00 | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 0% | 198 | $0.00 |
| 1159F | 0% | 153 | $0.00 | |
| 99072 | 0% | 15 | $0.00 | |
| 3050F | 0% | 43 | $0.00 | |
| 3008F | 0% | 3,448 | $0.00 | |
| 3075F | 0% | 555 | $0.00 | |
| 3074F | 0% | 1,361 | $0.00 | |
| 3048F | 0% | 841 | $0.00 | |
| 1125F | 0% | 490 | $0.00 | |
| 3079F | 0% | 453 | $0.00 | |
| 3049F | 0% | 218 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 15 | $0.00 |
| 80320 | 0% | 45 | $0.00 | |
| 1170F | 0% | 50 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETERS, LENIN (CEO)
Parent organizationBETHANY MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| Bethany Medical Center | High Point, NC | $18.31M |
| Bethany Medical Center | Greensboro, NC | $7.28M |
| Bethany Medical Center | Greensboro, NC | $5.72M |
| Bethany Medical Center | Winston Salem, NC | $5.13M |
| Bethany Medical Center | High Point, NC | $3.77M |
| Bethany Medical Center | Kernersville, NC | $2.29M |
| Bethany Medical Center | Greensboro, NC | $1.70M |
| Bethany Medical Center | Kernersville, NC | $1.62M |
| Bethany Medical Center | Mount Airy, NC | $1.50M |
| Bethany Medical Center, PA | High Point, NC | $1.47M |
| Bethany Medical Center PA | High Point, NC | $1.25M |
| Bethany Medical Center PA | High Point, NC | $1.13M |
| Bethany Medical Center, PA | High Point, NC | $645K |
| Bethany Medical Center | High Point, NC | $524K |
| LJP Anesthesia Services, PLLC | High Point, NC | $198K |
| Bethany Medical Center | High Point, NC | $88K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.